Patents by Inventor Robert CHUDNOW

Robert CHUDNOW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10688070
    Abstract: A preparation for treatment and/or prevention of seizures comprising a non-mammalian derived mixture of serine glycerophospholipids (PS) conjugates, wherein the mixture comprises (a) Eicosapentaenoic acid (EPA) conjugated to PS and (b) Docosahexaenoic acid (DHA) conjugated to PS, and methods of treatment of seizures with same.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: June 23, 2020
    Assignee: ENZYMOTEC LTD.
    Inventors: Daphna Zaaroor Regev, Yael Herzog, Robert Chudnow, Yael Richter, Gali Olga Soria Artzi
  • Publication number: 20170360812
    Abstract: The preparation of the present invention was found to be effective for the majority of patients diagnosed with autism. In patients characterized by delayed language development and non-expressive/non-emotional communication patterns, the preparation of the invention was found to be more effective than in patients that were diagnosed with autism without delayed language development and with expressive/emotional communication patterns, even though all patients consumed the preparation for a similar duration. Specific analysis for the type and quality of the improvement detected within the group of patients characterized by delayed language development and non-expressive/non-emotional communication patterns revealed that the majority of patients improved in various communication abilities: speech, language, conversation, and social play.
    Type: Application
    Filed: November 19, 2015
    Publication date: December 21, 2017
    Applicant: ENZYMOTEC LTD.
    Inventors: Daphna Zaaroor Regev, Robert Chudnow, Yael Richter, Olga Gali Soria Artzi
  • Publication number: 20160374974
    Abstract: A preparation for treatment and/or prevention of seizures comprising a non-mammalian derived mixture of serine glycerophospholipids (PS) conjugates, wherein the mixture comprises (a) Eicosapentaenoic acid (EPA) conjugated to PS and (b) Docosahexaenoic acid (DHA) conjugated to PS, and methods of treatment of seizures with same.
    Type: Application
    Filed: December 5, 2014
    Publication date: December 29, 2016
    Inventors: Daphna ZAAROOR REGEV, Yael HERZOG, Robert CHUDNOW, Yael RICHTER, Gali Olga SORIA ARTZI